Clinical Trial Update: Selenium as Augmentation Treatment for Sertraline Resistant Major Depression [NA]

View source ↗

Summary

A clinical trial evaluating selenium augmentation for sertraline-resistant major depressive disorder has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Selenium (selenium)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Major Depression | NA | Status: SUSPENDED